SCHEMBL110638

SCHEMBL110638

COc1c(N)cccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
TSHR P16473 3/20 0.48
BCHE P06276 5/20 0.48
ACHE P22303 5/20 0.48
NR4A2 P43354 1/20 0.46
CYP3A4 P08684 1/20 0.44
PIK3CA P42336 1/20 0.44
ADRA2B P18089 1/20 0.43
PTGS1 P23219 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HTR1A P08908 1/20 0.40
HTR1D P28221 1/20 0.40
HTR2C P28335 1/20 0.40
HTR7 P34969 1/20 0.40
HTR5A P47898 1/20 0.40
KDM4E B2RXH2 3/20 0.39
HSD17B10 Q99714 1/20 0.39
NPC1 O15118 2/20 0.39
GAA P10253 1/20 0.39
TUBB4A P04350 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29398608 1.00 ALDH1A1 (0.52) ALDH1A1TSHRBCHEACHENR4A2
SCHEMBL254822 0.83 KDM4E (0.46) ALDH1A1TSHRKDM4EHSD17B10NPC1
SCHEMBL358326 0.83 ALDH1A1 (0.52) ALDH1A1TSHRCYP3A4PIK3CAADRA2B
Hydrochloric Acid SCHEMBL4332744 0.80 ALDH1A1 (0.50) ALDH1A1TSHRCYP3A4PIK3CAADRA2B
SCHEMBL29048096 0.78 KDM4E (0.43) ALDH1A1TSHRKDM4EHSD17B10NPC1
SCHEMBL10437707 0.77 ALDH1A1 (0.47) ALDH1A1TSHRBCHEACHENR4A2
SCHEMBL3789699 0.77 ALDH1A1 (0.47) ALDH1A1TSHRBCHEACHENR4A2
SCHEMBL3785150 0.77 ALDH1A1 (0.48) ALDH1A1TSHRBCHEACHENR4A2
SCHEMBL9627789 0.77 CYP3A4 (0.50) ALDH1A1TSHRBCHEACHECYP3A4
SCHEMBL2203933 0.76 ALDH1A1 (0.46) ALDH1A1TSHRCYP3A4PIK3CAADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104744311-A Synthesis method of bifenazate MAISON CHEMICAL CO LTD 2015-07-01 CN claimed
CN-103613600-A Anilino podophyllotoxin derivative with anti-tumor activity and preparation method and application thereof UNIV HUBEI TECHNOLOGY 2014-03-05 CN claimed
EP-3959211-B1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS BAYER AG (DE) 2026-02-18 EP disclosed
EP-3958865-B1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES BAYER AG (DE) 2025-12-10 EP disclosed
US-12403135-B2 4H-pyrrolo[3,2-c]pyridin-4-one derivatives BAYER AKTIENGESELLSCHAFT (DE) 2025-09-02 US disclosed
US-20250197391-A1 METHODS OF SYNTHESIZING EGFR INHIBITORS ANTARES THERAPEUTICS, INC. 2025-06-19 US disclosed
US-20250136599-A1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2025-05-01 US disclosed
CN-119698415-A Methods of synthesizing EGFR inhibitors 蝎子疗法股份有限公司 2025-03-25 CN disclosed
EP-4499635-A1 METHODS OF SYNTHESIZING EGFR INHIBITORS Scorpion Therapeutics, Inc. (US) 2025-02-05 EP disclosed
US-20240408093-A1 HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE HALDA THERAPEUTICS OPCO, INC. 2024-12-12 US disclosed
CN-118852213-A Pyrrole fused heterocyclic derivative and application thereof in medicine 西藏海思科制药有限公司 2024-10-29 CN disclosed
US-4193937-A DECHLORINATION OF CHLOROANILINES, SELECTIVE HYDROGENATION CATALYSTS OF NOBLE METAL AND SULFUR BAYER AKTIENGESELLSCHAFT (DE) 1980-03-18 US disclosed
US-4112100-A INCREASING THE ENDOGENOUS PRODUCTION OF PROSTAGLANDINS THE UPJOHN COMPANY (US) 1978-09-05 US disclosed
US-4096157-A PIGMENTS HOECHST AKTIENGESELLSCHAFT (DT) 1978-06-20 US disclosed
US-4088766-A PRODUCTION OF PROSTAGLANDINS IN MAMMALS THE UPJOHN COMPANY (US) 1978-05-09 US disclosed
US-4085141-A Process for the preparation of anilines meta-substituted by chlorine BAYER AKTIENGESELLSCHAFT (DT) 1978-04-18 US disclosed
US-4001256-A PROSTAGLANDIN PRODUCTION IN MAMMALS THE UPJOHN COMPANY (US) 1977-01-04 US disclosed
US-3989756-A RANEY CATALYST, DEHALOGENATION INHIBITOR NIPPON KAYAKU KABUSHIKI KAISHA (JA) 1976-11-02 US disclosed
US-3965087-A Trisazo dye containing a diphenylenesulfone structure SAKAI CHEMICAL INDUSTRY COMPANY LTD. (JA) 1976-06-22 US disclosed
US-3951941-A POLYAZODYE SAKAI CHEMICAL INDUSTRY COMPANY, LIMITED (JA) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12403135-B2 4H-pyrrolo[3,2-c]pyridin-4-one derivatives EGFR, ERBB2, ERBB4 ALDH1A1 1255/4885TSHR 2270/4885BCHE 4221/4885
US-20250197391-A1 METHODS OF SYNTHESIZING EGFR INHIBITORS ERBB2, EGFR, ERBB3 ALDH1A1 2417/4885TSHR 444/4885BCHE 4324/4885
US-20240408093-A1 HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE FGFR3, FGFR1, ERBB3 ALDH1A1 4423/4885TSHR 3022/4885BCHE 3034/4885
US-20250136599-A1 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS CYP4B1, CYP2C19, PAH ALDH1A1 245/4885TSHR 1609/4885BCHE 1980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.